PRESIDENT HAS SERVED AS A REVIEWER FOR THE BST-F (80) BIOENGINEERING ‘ACADEMIC RESEARCH ENHANCEMENT AWARD’ STUDY SECTION FOR THE NIH

PDX Pharma’s President has served as a reviewer for the BST-F (80) Bioengineering ‘Academic Research Enhancement Award’ Study Section for the National Institute of Health (NIH) held on March 9, 2017.

pdx news

  • Mr. Bejan has been accepted into Oregon Health and Science University’s PhD program as an ARCS Scholar

    4/29/2019
    read more

  • Dr. Ngamcherdtrakul presents at the 2nd Annual Formulation & Drug Delivery USA Congress.

    3/20/2019
    read more

  • Data on Functionalized Mesoporous Silica for Removing Heavy Metals Accepted for Publication in Scientific Reports (IF = 4.122)

    1/29/2019
    read more

Copyright © 2017 PDX Pharmaceuticals, LLC. All rights reserved